Ritodrine hydrochloride: A betamimetic agent for use in preterm labor: I. pharmacology, clinical history, administration, side effects, and safety

Tom P. Barden, John B. Peter, Irwin R. Merkatz

Research output: Contribution to journalArticle

117 Scopus citations

Abstract

Ritodrine hydrochloride has become the first drug approved in the United States specifically for use in preterm labor. The drug is a β-sympathomimetic agent with predominant effects upon β2receptors of the uterus. In this report, the pharmacology, distribution, disposition, and excretion are briefly reviewed. Recommendations for selecting patients most likely to benefit from ritodrine are given, together with the dosage and administration schedules that have been found most effective. Although this drug is not without side effects, it has been more thoroughly evaluated in prospective double-blind controlled trials than any of the other agents commonly used in preterm labor. In comparison with these agents, it seems relatively safe and the side effects are usually well tolerated. Part 2 of the paper discusses the evidence for efficacy.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalObstetrics and gynecology
Volume56
Issue number1
StatePublished - Jul 1980
Externally publishedYes

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Ritodrine hydrochloride: A betamimetic agent for use in preterm labor: I. pharmacology, clinical history, administration, side effects, and safety'. Together they form a unique fingerprint.

  • Cite this